Avantax Advisory Services Inc. bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 14,133 shares of the company's stock, valued at approximately $494,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Public Employees Retirement System of Ohio grew its position in shares of Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after buying an additional 332 shares during the last quarter. State of Michigan Retirement System boosted its stake in Option Care Health by 1.2% in the first quarter. State of Michigan Retirement System now owns 40,759 shares of the company's stock valued at $1,425,000 after acquiring an additional 500 shares in the last quarter. Louisiana State Employees Retirement System grew its holdings in Option Care Health by 1.1% in the first quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company's stock worth $1,667,000 after purchasing an additional 500 shares during the last quarter. State of Alaska Department of Revenue increased its position in shares of Option Care Health by 2.7% during the first quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock worth $696,000 after purchasing an additional 525 shares in the last quarter. Finally, Mackenzie Financial Corp lifted its holdings in shares of Option Care Health by 1.1% during the 4th quarter. Mackenzie Financial Corp now owns 49,579 shares of the company's stock valued at $1,150,000 after purchasing an additional 556 shares during the last quarter. Institutional investors own 98.05% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on OPCH. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. Barrington Research reissued an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research report on Thursday, July 10th. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Finally, JMP Securities increased their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a report on Thursday, July 31st. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, Option Care Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $35.75.
Check Out Our Latest Analysis on OPCH
Option Care Health Stock Performance
Shares of OPCH stock opened at $28.10 on Wednesday. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The stock has a 50 day simple moving average of $30.90 and a 200-day simple moving average of $31.97. The company has a market cap of $4.56 billion, a price-to-earnings ratio of 22.48, a price-to-earnings-growth ratio of 1.79 and a beta of 0.79. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53.
Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same period in the prior year, the business earned $0.30 earnings per share. The company's quarterly revenue was up 15.4% on a year-over-year basis. On average, equities analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.